FindTrial
Sign In

Clinical study on surgical treatment of Ebstein malformation in infants

Clinical study on Tricuspid valvuloplasty treatment of Ebstein malformation in infant

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048174
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ebstein Anomaly

Interventions

Case series:No

Sponsors

The Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent signed and dated by the guardian (subjects indicated willingness to complete all steps and intervention cycles in the study); 2. Infants aged 0 to 3 years, regardless of gender; 3. Ebstein malformation was diagnosed by echocardiography before operation; 4. Preoperative echocardiography showed left ventricular ejection fraction (LVEF) >= 50%;

Exclusion criteria

Exclusion criteria: 1. Combined with other cardiac abnormalities; 2. Combined with chromosomal abnormalities; 3. There was severe cardiac insufficiency before operation.

Design outcomes

Primary

MeasureTime frame
Tricuspid regurgitation area;Right atrial diastolic diameter;pulmonary arterial systolic pressure;left ventricular ejection fraction;time of operation;cardiopulmonary bypass time;aortic crossclamp time;B-type natriuretic peptide;adverse event rate;—

Countries

China

Contacts

Public ContactZhou Gengxu

The seventh medical center of PLA General Hospital

cardiacsurgeon@126.com+86 15001395415

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026